Heather H. Cheng

Research interests

Publications

• Prostate Cancer, Version 3.2024

  Journal of the National Comprehensive Cancer Network · 2024 · https://doi.org/10.6004/jnccn.2024.0019

• Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

  European Journal of Cancer · 2023 · https://doi.org/10.1016/j.ejca.2023.02.018

• NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

  Journal of the National Comprehensive Cancer Network · 2023 · https://doi.org/10.6004/jnccn.2023.0051

• Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

  Journal of the National Comprehensive Cancer Network · 2023 · https://doi.org/10.6004/jnccn.2023.0050

• NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

  PubMed · 2022 · https://doi.org/10.6004/jnccn.2022.0063

• NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

  Journal of the National Comprehensive Cancer Network · 2021 · https://doi.org/10.6004/jnccn.2021.0008

• Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

  JAMA Oncology · 2020 · https://doi.org/10.1001/jamaoncol.2020.5161

• Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

  Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.19.02630

• Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

  Journal of Clinical Oncology · 2020 · https://doi.org/10.1200/jco.20.00046

• Germline and Somatic Mutations in Prostate Cancer for the Clinician

  Journal of the National Comprehensive Cancer Network · 2019 · https://doi.org/10.6004/jnccn.2019.7307

• Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer

  Journal of Clinical Investigation · 2019 · https://doi.org/10.1172/jci128212

• Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

  European Urology · 2019 · https://doi.org/10.1016/j.eururo.2019.02.002

• Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1603144

• Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.11.022

• Integrative Clinical Genomics of Advanced Prostate Cancer

  Cell · 2015 · https://doi.org/10.1016/j.cell.2015.05.001

• Quantitative and stoichiometric analysis of the microRNA content of exosomes

  Proceedings of the National Academy of Sciences · 2014 · https://doi.org/10.1073/pnas.1408301111

• Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels

  PLoS ONE · 2013 · https://doi.org/10.1371/journal.pone.0064795

• Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia

  PLoS ONE · 2013 · https://doi.org/10.1371/journal.pone.0069239

• MicroRNA profiling: approaches and considerations

  Nature Reviews Genetics · 2012 · https://doi.org/10.1038/nrg3198

• lazarus Is a Novel pbx Gene that Globally Mediates hox Gene Function in Zebrafish

  Molecular Cell · 2000 · https://doi.org/10.1016/s1097-2765(00)00027-7

Current projects

No projects listed.